Search | IOVS | ARVO Journals

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Biometric parameters and myopia in a canine model of open-angle glaucoma (OAG)

Christine Diane Harman; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3416. doi:

ARVO Annual Meeting Abstract July 2019

Fluorophotometric determination of aqueous humor flow rates (AHFRs) in a canine model of ADAMTS10 -Weill Marchesani syndrome-associated open-angle glaucoma (WMS-OAG)

Christine Harman; Kristin L Koehl; Carol B Toris; Leandro B C Teixeira; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5121. doi:

ARVO Annual Meeting Abstract July 2019

Safety and long-term efficacy of AAV2- BEST1 gene augmentation therapy in canine model of Best vitelliform macular dystrophies

Karina E Guziewicz; Artur V Cideciyan; Brian T. Kendrick; Valerie L Dufour; Gordon Ruthel; Andras M Komaromy; Simone Iwabe; William Hauswirth; William A Beltran; Samuel G Jacobson; Gustavo D Aguirre

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5200. doi:

ARVO Annual Meeting Abstract July 2019

Long-term stable intraocular pressure (IOP) control and optic nerve head (ONH) preservation following AAV-mediated ocular gene therapy in a canine model of ADAMTS10 -open-angle glaucoma (OAG)

Andras M Komaromy; Kristin L Koehl; Christine Harman; Sanford L Boye; Juan P. Steibel; Leandro B C Teixeira; Carol B Toris; Sayoko Eileen Moroi; Shannon Elizabeth Boye

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6470. doi:

ARVO Annual Meeting Abstract July 2019

Safety and efficacy of topically administered netarsudil (Rhopressa™) in normal and glaucomatous dogs with ADAMTS10 -open-angle glaucoma ( ADAMTS10 -OAG)

Kelly A Leary; Kuan-Ting Lin; Juan P. Steibel; Christine Harman; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3784. doi:

ARVO Annual Meeting Abstract July 2018

BEST1 gene augmentation therapy corrects light-modulated retinal micro-detachments

Karina E Guziewicz; Artur V Cideciyan; William A Beltran; Andras M Komaromy; Valerie Dufour; Malgorzata Swider; Simone Iwabe; Alexander Sumaroka; Brian T Kendrick; Gordon Ruthel; Vince A Chiodo; Elise Heon; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4522. doi:

ARVO Annual Meeting Abstract June 2017

Outcome measures for BEST1 gene augmentation therapy: restoration of RPE-photoreceptor interface homeostasis

Karina E Guziewicz; William A Beltran; Artur V Cideciyan; Valerie Liliane Dufour; Andras M Komaromy; Emily McTish; Alfred S Lewin; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2273. doi:

ARVO Annual Meeting Abstract June 2017

Long-term intraocular Pressure (IOP) control by means of a novel biodegradable intracameral (IC) latanoprost free acid (LFA) implant

Andras M Komaromy; Kristin Koehl; Christine D Harman; Gabriel Stewart; Noah Wolinski; Taylor N Norris; David Valade; Igor Chekhtman; John N Lambert; Andrew C Donohue; Russell Tait

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4591. doi:

ARVO Annual Meeting Abstract June 2017

Safety of a novel biodegradable intracameral (IC) latanoprost free acid (LFA) implant for long-term intraocular pressure (IOP) control

Kristin Koehl; Christine Harman; Gabriel Stewart; Noah Wolinski; Taylor N Norris; David Valade; Andrew C Donohue; Igor Chekhtman; John N Lambert; Russell Tait; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4592. doi:

ARVO Annual Meeting Abstract June 2017

Optimization of transgene expression in the trabecular meshwork (TM) by comparing capsid mutant AAV2 vectors

Christine Harman; Kristin Koehl; Annie Oh; Vince A Chiodo; Sanford L Boye; William W Hauswirth; Shannon Elizabeth Boye; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4611. doi:

ARVO Annual Meeting Abstract June 2017

Quantitative and Qualitative Assessment of Retinal Degeneration in Canine Models of Inherited Retinal Diseases Using Spectral Domain Optical Coherence Tomography (SD-OCT)

Shin Ae Park; Jamie Rhodes; Simone Iwabe; Gui-Shuang Ying; J. Huang; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4869. doi:

ARVO Annual Meeting Abstract June 2015

Long-term Cone ERG Functional Rescue in CNGB3 Mutant Achromatopsia Dogs by AAV-hCNGB3 Vectors Containing the PR1.7 Promoter and Packaged in AAV5, AAV9 or Mutant AAV2 Capsids

Andras M Komaromy; Guo-jie Ye; Christine Harman; Kristin L Koehl; Gustavo D Aguirre; Savitri Mandapati; Jeffrey D Chulay

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2066. doi:

ARVO Annual Meeting Abstract June 2015

In Vivo Gene Augmentation in the ADAMTS10 -Mutant Canine Trabecular Meshwork (TM) with Y444F-Capsid Mutant, Single-Stranded AAV2

Christine Harman; Annie Oh; Kristin L Koehl; Sanford L Boye; Vince Chiodo; Jiayan Huang; Gui-Shuang Ying; Shannon Elizabeth Boye; William W Hauswirth; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3648. doi:

ARVO Annual Meeting Abstract June 2015

Incomplete Achromatopsia in a Subgroup of Related CNGB3 -Mutant Dog

Kristin Koehl; Joshua Laske; Jennifer Rivera-Avales; Christine Harman; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4651. doi:

ARVO Annual Meeting Abstract June 2015

Assessment of rod, cone, and intrinsically photosensitive retinal ganglion cell (ipRGC) contribution to the canine chromatic pupillary response

Connie Yeh; Kristin L Koehl; Christine Harman; Simone Iwabe; Jose Guzman; Simon M Petersen-Jones; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5569. doi:

ARVO Annual Meeting Abstract April 2014

Photoreceptor-Targeted Gene Delivery Using Intravitreally Administered AAV Vectors in Dogs

Ryan F Boyd; Sanford L Boye; Shannon Boye; William W Hauswirth; Andras M Komaromy; Simon M Petersen-Jones; Joshua T Bartoe

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3331. doi:

ARVO Annual Meeting Abstract April 2014

Organotypic Culture System for the Adult Canine Retina

Hsiang-Rong Tsai; Ákos Lukáts; Arnold Szabo; Christine Diane Harman; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):360. doi:

ARVO Annual Meeting Abstract April 2014

Age effects on scleral mechanical properties of ADAMTS10-mutant and normal Beagle dogs

Joel Palko; Hugh J Morris; Xueliang Pan; Christine Diane Harman; Kristin Koehl; Kirk N Gelatt; Caryn Plummer; Andras M Komaromy; Jun Liu

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4264. doi:

ARVO Annual Meeting Abstract April 2014

Targeting of Gene Expression to the wildtype and ADAMTS10-Mutant Canine Trabecular Meshwork by Non-Self-Complementary AAV2

Annie Oh; Christine Diane Harman; Kristin Koehl; Vince Chiodo; Sanford L Boye; Shannon Boye; William W Hauswirth; Andras M Komaromy

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5669. doi:

ARVO Annual Meeting Abstract April 2014

Disease-based promoter selection for retinal gene therapy

Gustavo D Aguirre; Sem Genini; Andras M Komaromy; Karina E Guziewicz; William A Beltran

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):838. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Biometric parameters and myopia in a canine model of open-angle glaucoma (OAG)

Fluorophotometric determination of aqueous humor flow rates (AHFRs) in a canine model of ADAMTS10 -Weill Marchesani syndrome-associated open-angle glaucoma (WMS-OAG)

Safety and long-term efficacy of AAV2- BEST1 gene augmentation therapy in canine model of Best vitelliform macular dystrophies

Long-term stable intraocular pressure (IOP) control and optic nerve head (ONH) preservation following AAV-mediated ocular gene therapy in a canine model of ADAMTS10 -open-angle glaucoma (OAG)

Safety and efficacy of topically administered netarsudil (Rhopressa™) in normal and glaucomatous dogs with ADAMTS10 -open-angle glaucoma ( ADAMTS10 -OAG)

BEST1 gene augmentation therapy corrects light-modulated retinal micro-detachments

Outcome measures for BEST1 gene augmentation therapy: restoration of RPE-photoreceptor interface homeostasis

Long-term intraocular Pressure (IOP) control by means of a novel biodegradable intracameral (IC) latanoprost free acid (LFA) implant

Safety of a novel biodegradable intracameral (IC) latanoprost free acid (LFA) implant for long-term intraocular pressure (IOP) control

Optimization of transgene expression in the trabecular meshwork (TM) by comparing capsid mutant AAV2 vectors

Quantitative and Qualitative Assessment of Retinal Degeneration in Canine Models of Inherited Retinal Diseases Using Spectral Domain Optical Coherence Tomography (SD-OCT)

Long-term Cone ERG Functional Rescue in CNGB3 Mutant Achromatopsia Dogs by AAV-hCNGB3 Vectors Containing the PR1.7 Promoter and Packaged in AAV5, AAV9 or Mutant AAV2 Capsids

In Vivo Gene Augmentation in the ADAMTS10 -Mutant Canine Trabecular Meshwork (TM) with Y444F-Capsid Mutant, Single-Stranded AAV2

Incomplete Achromatopsia in a Subgroup of Related CNGB3 -Mutant Dog

Assessment of rod, cone, and intrinsically photosensitive retinal ganglion cell (ipRGC) contribution to the canine chromatic pupillary response

Photoreceptor-Targeted Gene Delivery Using Intravitreally Administered AAV Vectors in Dogs

Organotypic Culture System for the Adult Canine Retina

Age effects on scleral mechanical properties of ADAMTS10-mutant and normal Beagle dogs

Targeting of Gene Expression to the wildtype and ADAMTS10-Mutant Canine Trabecular Meshwork by Non-Self-Complementary AAV2

Disease-based promoter selection for retinal gene therapy

To View More...

You must be signed into an individual account to use this feature.